Ken Griffin I Teos Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 32,100 shares of ITOS stock, worth $274,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,100

Previous 23,900 34.31%

Holding current value

$274,134

Previous $354,000 7.63%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.09 - $17.97 $5.44 Million - $9.68 Million	538,927 Added 77.28%	1,236,259 $12.6 Million
Q2 2024 Aug 14, 2024	SELL	$10.33 - $18.09 $4.87 Million - $8.53 Million	-471,332 Reduced 40.33%	697,332 $10.3 Million
Q1 2024 May 15, 2024	BUY	$9.89 - $13.64 $384,483 - $530,268	38,876 Added 3.44%	1,168,664 $15.9 Million
Q4 2023 Feb 14, 2024	BUY	$8.57 - $11.06 $1.05 Million - $1.35 Million	122,216 Added 12.13%	1,129,788 $12.4 Million
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $2.06 Million - $2.74 Million	-187,697 Reduced 15.7%	1,007,572 $11 Million
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.05 $3.21 Million - $4.48 Million	-248,231 Reduced 17.2%	1,195,269 $15.8 Million
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $1.15 Million - $1.99 Million	88,073 Added 6.5%	1,443,500 $19.6 Million
Q4 2022 Feb 14, 2023	BUY	$17.77 - $21.6 $596,076 - $724,550	33,544 Added 2.54%	1,355,427 $26.5 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $11.3 Million - $16.6 Million	608,171 Added 85.21%	1,321,883 $25.2 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $3.19 Million - $6.75 Million	192,241 Added 36.87%	713,712 $14.7 Million
Q1 2022 May 16, 2022	SELL	$31.92 - $47.45 $15.2 Million - $22.7 Million	-477,470 Reduced 47.8%	521,471 $16.8 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $617,008 - $1.13 Million	23,523 Added 2.41%	998,941 $0
Q3 2021 Nov 15, 2021	SELL	$23.91 - $29.58 $453,763 - $561,369	-18,978 Reduced 1.91%	975,418 $26.3 Million
Q2 2021 Aug 16, 2021	BUY	$17.9 - $36.1 $8.65 Million - $17.5 Million	483,398 Added 94.6%	994,396 $0
Q1 2021 May 17, 2021	SELL	$30.86 - $44.2 $8.84 Million - $12.7 Million	-286,316 Reduced 35.91%	510,998 $17.5 Million
Q4 2020 Feb 16, 2021	SELL	$21.59 - $33.95 $2.18 Million - $3.43 Million	-100,975 Reduced 11.24%	797,314 $27 Million
Q3 2020 Nov 16, 2020	BUY	$17.57 - $32.92 $15.8 Million - $29.6 Million	898,289 New	898,289 $22.2 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $304M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account